Skip to main content
NRx Defense Systems, Inc. logo

NRx Defense Systems, Inc.

North Bay Village, Florida, United StatesSee on the map

  • Neuromodulation
  • Depression

NRx Defense Systems is a clinical technology company developing neuroscience-based treatments for PTSD, depression, and suicidality among military personnel, veterans, first responders, and other service populations. Its platform combines MRI neuronavigation, robotic transcranial magnetic stimulation (TMS), and investigational neuroplastic medication, with an $11 million DARPA prime contract supporting its evaluation.

Open roles
3
Raised
$40.7M

reccy insights

Recent highlights

NRx Defense Systems has advanced its clinical and defense-focused neuroscience pipeline through significant capital raises and high-profile research collaborations. On April 17, 2025, the company secured $20,000,000 through an ATM offering, followed by an additional $20,716,000 via an underwritten public offering on June 4, 2026, bringing its total tracked funding to nearly $33 million. The company is actively developing advanced treatments for treatment-resistant PTSD, depression, and suicidality among military personnel, veterans, and first responders. A cornerstone of its recent momentum is an $11 million prime contract from DARPA, which supports the evaluation of robotically controlled transcranial magnetic stimulation (TMS) combined with the investigational neuroplastic medication NRX-101. Furthermore, NRx Defense Systems has established strategic clinical and research partnerships with institutions such as Harvard McLean Hospital and HOPE Therapeutics to accelerate the deployment of its precision neuromodulation protocols.

Written by reccy's AI from company sites, press and funding records · updated Nov 2026

Open roles3

What makes NRx Defense Systems, Inc. distinct

  1. 01Combines MRI neuronavigation, robotic TMS, and investigational neuroplastic medication in a precision treatment protocol.
  2. 02Focuses on treatment-resistant PTSD and depression in military and other service populations.
  3. 03Holds an $11 million DARPA prime contract to evaluate robotic magnetic stimulation with NRX-101.
  4. 04Works with Harvard McLean Hospital and HOPE Therapeutics on research and clinical deployment.
  5. 05Brings together clinicians, neuroscience researchers, engineers, veterans, and defense-sector leaders.

Technology & products

  • NRX-101 Protocol

    An investigational neuroplastic medication combined with MRI neuronavigation and robotic TMS for treatment-resistant PTSD and depression.

  • MRI neuronavigation
  • Robotically controlled transcranial magnetic stimulation (TMS)
  • Integrated TMS and neuroplastic medication protocol
  • NRX-101, an investigational neuroplastic medication

Funding

$40.7M disclosed
  • Underwritten Public OfferingJun 2026
    $20.7M
  • ATM OfferingApr 2025
    $20M

Similar companies

About NRx Defense Systems, Inc.

Products
NRX-101 Protocol
Focus areas
Mental health, neuromodulation, tms, military health, ptsd, depression, clinical research, defense technology
Headquarters
North Bay Village, Florida, United States